Peripheral T Cell Lymphoma Clinical Trials in Shanghai, Shanghai Municipality
12 recruitingShanghai, Shanghai Municipality, China
Showing 1–12 of 12 trials
Recruiting
Phase 2
Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma
Peripheral T Cell Lymphoma
Fudan University51 enrolled1 locationNCT04512534
Recruiting
Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study
Peripheral T Cell Lymphoma
Fudan University3,000 enrolled1 locationNCT07270861
Recruiting
T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine58 enrolled1 locationNCT07470996
Recruiting
Phase 3
Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine68 enrolled1 locationNCT07414758
Recruiting
Phase 2Phase 3
A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine40 enrolled1 locationNCT07389616
Recruiting
Phase 1Phase 2
Evaluate the Safety and Clinical Activity of HH2853
Advanced Solid TumorPeripheral T Cell LymphomaFL Lymphoma+1 more
Haihe Biopharma Co., Ltd.254 enrolled25 locationsNCT04390737
Recruiting
T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine160 enrolled1 locationNCT07353840
Recruiting
Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine88 enrolled1 locationNCT07253129
Recruiting
Phase 3
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
Peripheral T Cell Lymphoma
Dizal Pharmaceuticals218 enrolled50 locationsNCT07234162
Recruiting
Phase 2
RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.
Peripheral T Cell Lymphoma
Xianmin Song, MD50 enrolled1 locationNCT06468267
Recruiting
Not Applicable
Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine50 enrolled1 locationNCT06509945
Recruiting
Phase 1Phase 2
Genotype-guided Treatment in Newly Diagnosed PTCL
Peripheral T Cell Lymphoma
Ruijin Hospital264 enrolled1 locationNCT05675813